Dr Nguyễn Thanh Thùy Nhiên

Vice Head of Malaria

Dr Thuy Nhien joined OUCRU in June 2010 and has experience as an investigator involved in many clinical trials/laboratory researches related to anti-malarial drug resistance, new drug development, and genetic surveillance and supervised the Malaria laboratory.

Dr Thuy Nhien is leading genetic surveillance activities in Vietnam, in close collaboration with Vietnam NMCPs, GenRe-Mekong project, MORU and Wellcome Sanger Institute (UK) to monitor and understand how drug resistance emerges and spreads in malaria parasites and provide timely quality information to support drug policy decision marking.

Dr Thuy Nhien’s current research focuses on drug resistance molecular markers, molecular epidemiology of drug resistance in Vietnam and GMS, and malaria elimination.

Publikasi Saya

Chau Van Khanh, H%u01B0%u01A1ng Giang L%EA, Tu%u1EA5n C%u01B0%u1EDDng V%F5, Nguyen Xuan Quang, Do Van Nguyen, Nguyen Cong Trung Dung, Le Thanh Tam, Nguyen Thanh Thuy Nhien, %u0110%u0103ng Th%F9y D%u01B0%u01A1ng Nguy%u1EC5n, Thu H%u1EB1ng Nguy%u1EC5n, Tran Thi Hue Van, Le Duc Vinh, Pham Minh Quan, Nguyen Kim Trung, Jung-Mi Kang, Byoung-Kuk Na, Huynh Hong Quang

Emerg Microbes Infect

November 19, 2024

DOI: 10.1080/22221751.2024.2432359

Varanya Wasakul, Areeya Disratthakit, Mayfong Mayxay, Keobouphaphone Chindavongsa, Viengphone Sengsavath, Nguyen Thuy-Nhien, Richard D Pearson, Sonexay Phalivong, Saiamphone Xayvanghang, Richard J Maude, Sonia Goncalves, Nicholas P Day, Paul N Newton, Elizabeth A Ashley, Dominic P Kwiatkowski, Arjen M Dondorp, Olivo Miotto

Lancet Infect Dis

November 30, 2022

DOI: 10.1016/S1473-3099(22)00697-1

MalariaGEN, Ishag Adam, Mohammad Shafiul Alam, Nguyen Hoang Chau, Tran Tinh Hien, Thuy-Nhien Nguyen etc. Daniel Yilma

Wellcome Open Res

April 14, 2022

DOI: 10.12688/wellcomeopenres.17795.1

WorldWide Antimalarial Resistance Network Methodology Study Group (including Tran Tinh Hien, Nguyen Thuy-Nhien)

Malar J

Maret 24, 2022

DOI: 10.1186/s12936-021-03980-z

Mallika Imwong, Kanokon Suwannasin, Suttipat Srisutham, Ranitha Vongpromek, Cholrawee Promnarate, Aungkana Saejeng, Aung Pyae Phyo, Stephane Proux, Tiengkham Pongvongsa, Chea Nguon, Olivo Miotto, Rupam Tripura, Nguyen Hoang Chau, Dysoley Lek, Ho Dang Trung Nghia, Thomas J Peto, James J Callery, Rob W van der Pluijm, Chanaki Amaratunga, Mavuto Mukaka, Lorenz von Seidlein, Mayfong Mayxay, Nguyen Thanh Thuy-Nhien et al.

Antimicrob Agents Chemother

September 13, 2021

DOI: 10.1128/AAC.01121-21